Brian Lian - 29 Jul 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
29 Jul 2024
Net transactions value
-$6,670,604
Form type
4
Filing time
31 Jul 2024, 16:05:07 UTC
Previous filing
27 Mar 2024
Next filing
19 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +41,000 +1.8% $0.000000 2,307,453 29 Jul 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +163,333 +7.1% $0.000000 2,470,786 29 Jul 2024 Direct F2
transaction VKTX Common Stock, par value $0.00001 per share Sale $3,755,340 -65,941 -2.7% $56.95 2,404,845 30 Jul 2024 Direct F3, F4
transaction VKTX Common Stock, par value $0.00001 per share Sale $1,127,353 -19,501 -0.81% $57.81 2,385,344 30 Jul 2024 Direct F3, F5
transaction VKTX Common Stock, par value $0.00001 per share Sale $1,787,911 -30,417 -1.3% $58.78 2,354,927 30 Jul 2024 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were subject to a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal.
F2 The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2024, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal.
F3 These shares were automatically sold on a non-discretionary basis soley to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.46 to $57.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.46 to $58.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.46 to $59.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.